Article
The Genomic Era of Clinical Oncology: Integrated Genomic Analysis for Precision Cancer Care
1 Jan 2016
Abstract excerpt
Genomic alterations are important biological markers for cancer diagnosis and prognosis, disease classification, risk stratification, and treatment selection. Chromosomal microarray analysis (CMA) and next-generation sequencing (NGS) technologies are superb new tools for evaluating cancer genomes. These state-of-the-art technologies offer high-throughput, highly accurate, targeted and whole-genome evaluation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
